目的:探究血清β-人绒毛膜促性腺激素(β-HCG)及碱性磷酸酶(ALP)水平检测联合经腹部彩超在宫外孕早期诊断中的应用价值。方法:选取2017年3月至2018年3月在我院产科诊治的宫外孕患者47例为宫外孕组,同期选取正常妊娠孕妇51例作为正常妊娠...目的:探究血清β-人绒毛膜促性腺激素(β-HCG)及碱性磷酸酶(ALP)水平检测联合经腹部彩超在宫外孕早期诊断中的应用价值。方法:选取2017年3月至2018年3月在我院产科诊治的宫外孕患者47例为宫外孕组,同期选取正常妊娠孕妇51例作为正常妊娠组,回顾性分析各研究对象血清中β-HCG、ALP水平和经腹部彩超测得的子宫内是否有孕囊、内膜厚度等指标并进行比较。结果:宫外孕组腹痛、阴道出血、腹部压痛、子宫增大、附件区压痛、宫颈举痛等发生率显著高于正常妊娠组(P<0.05)。宫外孕组患者血清β-HCG水平显著低于正常妊娠组[(1554.12±279.21) vs (3267.98±610.21)mIU/mL,P <0.05];血清ALP水平明显低于正常妊娠组[(29.45±5.23) vs (42.37±9.72) mIU/mL,P <0.05]。Spearman检验结果显示,宫外孕组患者血清β-HCG与ALP水平呈明显正相关(r=0.630,P <0.05)。宫外孕组子宫内膜厚度≤10mm、附件区有包块、宫内无孕囊、无胎心搏动等发生率明显高于正常妊娠组(P<0.05)。血清β-HCG、ALP检测联合经腹部彩超检测诊断宫外孕特异性较高,为96.08%。结论:血清β-HCG、ALP指标联合经腹部彩超检测可明显提高宫外孕早期诊断的特异性,具有一定临床推广意义。展开更多
Objective： To study the clinical effects of Prescription Zhuyun-Ⅲ （助孕3号方, ZYⅢ） on early pregnant women diagnosed as threatened abortion, and its mechanism in immunity and endocrine by determining serum Th1- a...Objective： To study the clinical effects of Prescription Zhuyun-Ⅲ （助孕3号方, ZYⅢ） on early pregnant women diagnosed as threatened abortion, and its mechanism in immunity and endocrine by determining serum Th1- and Th2-type cytokines, progesterone, and β-human chorionic gonadotropin （β-HCG）. Methods： The treatment group comprised 30 early pregnant women diagnosed as threatened abortion of deficiency syndrome of Pi （脾）, Shen （肾）, or both. The control group consisted of 20 normal early pregnant women of similar gestational age. Patients in the treatment group were administered with ZYⅢ for 4 weeks. Peripheral blood samples were collected pre- and post-treatment from both the treatment and the control groups. Serum Thl-type cytokine [interleukin-2 （IL-2）] and Th2-type cytokine [interleukin-10 （IL-10）] were determined by flow cytometry, and serum progesterone and 13-HCG were determined by ELISA. Results： （1） The treatment was effective in 26 and ineffective in 4 patients of the treatment group. Therefore, the cure percentage was 86.67%. （2） In the treatment group before the treatment, IL-2 was significantly higher, IL-10 tended to be less, and the Th1/Th2 balance shifted toward Thl compared with those in the control group. （3） After the treatment, IL-2 was decreased, IL-10 was increased, and IL-2/IL-10 was decreased. Both progesterone and β-HCG were increased. Changes of progesterone were positively correlated with changes of IL-10, whereas changes of β-HCG were negatively correlated with changes of IL-2. Conclusions： Our study suggests that ZYⅢ has an evident function of protecting the fetus, and one of its mechanisms is inhibiting the secretion of Thl cytokines, promoting the secretion of Th2 cytokines, and recovering the pathological shift of the Th1/Th2 balance. The other possible mechanism is increasing serum progesterone and β-HCG concentrations. Moreover, there are some correlations between the above two effects.展开更多
文摘目的:探究血清β-人绒毛膜促性腺激素(β-HCG)及碱性磷酸酶(ALP)水平检测联合经腹部彩超在宫外孕早期诊断中的应用价值。方法:选取2017年3月至2018年3月在我院产科诊治的宫外孕患者47例为宫外孕组,同期选取正常妊娠孕妇51例作为正常妊娠组,回顾性分析各研究对象血清中β-HCG、ALP水平和经腹部彩超测得的子宫内是否有孕囊、内膜厚度等指标并进行比较。结果:宫外孕组腹痛、阴道出血、腹部压痛、子宫增大、附件区压痛、宫颈举痛等发生率显著高于正常妊娠组(P<0.05)。宫外孕组患者血清β-HCG水平显著低于正常妊娠组[(1554.12±279.21) vs (3267.98±610.21)mIU/mL,P <0.05];血清ALP水平明显低于正常妊娠组[(29.45±5.23) vs (42.37±9.72) mIU/mL,P <0.05]。Spearman检验结果显示,宫外孕组患者血清β-HCG与ALP水平呈明显正相关(r=0.630,P <0.05)。宫外孕组子宫内膜厚度≤10mm、附件区有包块、宫内无孕囊、无胎心搏动等发生率明显高于正常妊娠组(P<0.05)。血清β-HCG、ALP检测联合经腹部彩超检测诊断宫外孕特异性较高,为96.08%。结论:血清β-HCG、ALP指标联合经腹部彩超检测可明显提高宫外孕早期诊断的特异性,具有一定临床推广意义。
基金Supported by Guangdong Province Key Scientific and Technological Project(No.C30103)
文摘Objective： To study the clinical effects of Prescription Zhuyun-Ⅲ （助孕3号方, ZYⅢ） on early pregnant women diagnosed as threatened abortion, and its mechanism in immunity and endocrine by determining serum Th1- and Th2-type cytokines, progesterone, and β-human chorionic gonadotropin （β-HCG）. Methods： The treatment group comprised 30 early pregnant women diagnosed as threatened abortion of deficiency syndrome of Pi （脾）, Shen （肾）, or both. The control group consisted of 20 normal early pregnant women of similar gestational age. Patients in the treatment group were administered with ZYⅢ for 4 weeks. Peripheral blood samples were collected pre- and post-treatment from both the treatment and the control groups. Serum Thl-type cytokine [interleukin-2 （IL-2）] and Th2-type cytokine [interleukin-10 （IL-10）] were determined by flow cytometry, and serum progesterone and 13-HCG were determined by ELISA. Results： （1） The treatment was effective in 26 and ineffective in 4 patients of the treatment group. Therefore, the cure percentage was 86.67%. （2） In the treatment group before the treatment, IL-2 was significantly higher, IL-10 tended to be less, and the Th1/Th2 balance shifted toward Thl compared with those in the control group. （3） After the treatment, IL-2 was decreased, IL-10 was increased, and IL-2/IL-10 was decreased. Both progesterone and β-HCG were increased. Changes of progesterone were positively correlated with changes of IL-10, whereas changes of β-HCG were negatively correlated with changes of IL-2. Conclusions： Our study suggests that ZYⅢ has an evident function of protecting the fetus, and one of its mechanisms is inhibiting the secretion of Thl cytokines, promoting the secretion of Th2 cytokines, and recovering the pathological shift of the Th1/Th2 balance. The other possible mechanism is increasing serum progesterone and β-HCG concentrations. Moreover, there are some correlations between the above two effects.
